chartexchange

RenovoRx Inc (RNXT) (Q3 2026) Earnings Call Highlights: Record Revenue, Expanding Commercial ...

GuruFocus | Nov 6, 2026 2:21 AM EST

RenovoRx Inc (RNXT) posts record quarterly revenue of $1.1 million, grows active cancer centers to 26, and advances its TAMP platform toward pivotal Phase III data in 2027. Related Stocks: RNXT ,

Read original article